Alcon's Retaane "Approvable" For Wet Age-Related Macular Degeneration
This article was originally published in The Pink Sheet Daily
Executive Summary
The firm plans to meet with FDA "to determine the steps necessary to gain final approval." Alcon says it will discuss ongoing studies with anecortave acetate. The ophthalmic agent passed manufacturing inspections, the firm reports.